0001209191-20-052116.txt : 20200925 0001209191-20-052116.hdr.sgml : 20200925 20200925171444 ACCESSION NUMBER: 0001209191-20-052116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200923 FILED AS OF DATE: 20200925 DATE AS OF CHANGE: 20200925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRASAD SUYASH CENTRAL INDEX KEY: 0001679129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39536 FILM NUMBER: 201200963 MAIL ADDRESS: STREET 1: C/O AUDENTES THERAPEUTICS, INC. STREET 2: 101 MONTGOMERY ST., SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 212.551.8702 MAIL ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-23 0 0001806310 Taysha Gene Therapies, Inc. TSHA 0001679129 PRASAD SUYASH C/O TAYSHA GENE THERAPIES, INC. 2280 INWOOD ROAD DALLAS TX 75235 0 1 0 0 CMO and Head of R&D Common Stock 2020-09-23 4 A 0 668745 A 668745 D The shares underlying the RSU vest in 4 equal annual installments on each of June 29, 2021, June 29, 2022, June 29, 2023 and June 29, 2024, subject to the Reporting Person's continuous service as of each such vesting date Each RSU represents a contingent right to receive one share the Issuer's common stock. /s/ Kamran Alam, Attorney-in-Fact 2020-09-25